AzTrials
AzTrials

DeliriumIMPROVENCT03095417

Improving the Recovery and Outcome Every Day After the ICU

A study testing Physical Exercise Intervention and Cognitive Training Intervention in people with Delirium and Alzheimer Disease, run by Indiana University at 6 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary Specific Aim: Determine the effect of the combined physical exercise and cognitive training on the cognitive function of ICU survivors aged 50 and older. Hypothesis: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 weeks of combined… Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Delirium, Alzheimer Disease
What is being tested?
Physical Exercise Intervention and Cognitive Training Intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
249 participants
Where
6 sitesUnited States
Study dates
25 Sep 2017to 15 Dec 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged ≥ 50 years
  • Admitted to medical and/or surgical ICUs at Methodist, University, or Eskenazi hospitals
  • Discharged home or to sub-acute rehabilitation, long-term acute care, or skilled nursing facility
  • Able to provide consent or has a legally authorized representative to provide consent
  • Access to a telephone (study provides computer and broadband)
  • Have at least one episode of subsyndromal delirium or delirium as determined by the Confusion Assessment Method for the ICU-7 (CAM-ICU).

Who cannot join

  • Diagnosis of cancer with short life expectancy
  • Current chemotherapy or radiation therapy (confirmed by electronic medical record)
  • History of dementing illnesses and other neurodegenerative disease such as Alzheimer's disease, Parkinson disease, or vascular dementia (confirmed by EMR), or current prescription of anti-dementia medication, or ruled out by Functional Activities Questionnaire (FAQ) score defining dementia
  • History of bipolar disorder or schizophrenia (confirmed by EMR)
  • Current alcohol consumption > 5 drinks per day (self reported and/or confirmed by EMR)
  • Vision < 20/80 via Snellen card or confirmed by EMR
Show all 17Show fewer
  • Low hearing or communicative ability (examiner rated) that would interfere with interventions and outcome assessments
  • Have any active and untreated American College of Sports Medicine absolute contraindications to exercise (confirmed by EMR) including: acute myocardial infarctions within the past 2 days, ongoing unstable angina, uncontrolled cardiac arrhythmia with hemodynamic compromise, active endocarditis, symptomatic severe aortic stenosis, decompensated heart failure, acute pulmonary embolism, pulmonary infarction, or deep venous thrombosis, acute myocarditis or pericarditis, acute aortic dissection, physical disability that precludes safe and adequate testing, or are unable to obtain provider clearance for physical exercise for any contraindication where medical management is unclear
  • Have any active and untreated American College of Sports Medicine relative contraindications to exercise (confirmed by EMR) including: known obstructive left main coronary stenosis, moderate to severe aortic stenosis with uncertain relationship to symptoms, tachydysrhythmias with uncontrolled ventricular rates, acquired advanced or complete heart block, recent stroke or transient ischemia attack, mental impairment with limited ability to cooperate, resting hypertension with systolic >200 mm Hg or diastolic >100 mm Hg, uncorrected medical conditions, such as significant anemia, important electrolyte imbalance, and hyperthyroidism, or are unable to obtain provider clearance for physical exercise for any contraindication where medical management is unclear
  • Recovering from a skeletal fracture (confirmed by EMR), unless cleared by their physician of record to safely participate in exercise
  • Acquired neurologic injury (stroke, traumatic brain injury, cerebral edema/swelling, anoxic brain injury, or any other acute/subacute severe neurologic deficit) as the admitting diagnosis or a new event during the course of hospitalization (confirmed by EMR)
  • History of drug abuse within the last 3 months confirmed by EMR or self-report with Drug Abuse and Screening Test (DAST-10) score ≥ 3
  • Have any spinal cord injury with persistent neurologic deficit at the time of study enrollment
  • Status post tracheostomy and not eligible for a speaking valve
  • Pregnant or nursing
  • Incarcerated or homeless at time of study
  • Lives outside the greater Indianapolis area

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United States6 sites
  • Indiana University Health West Hospital

    Avon, Indiana, 46123

  • Indiana University Health North Hospital

    Carmel, Indiana, 46032

  • Indiana University Health Saxony Hospital

    Fishers, Indiana, 46037

  • Eskenazi Health

    Indianapolis, Indiana, 46202

  • Indiana University Health Methodist Hospital

    Indianapolis, Indiana, 46202

  • Indiana University Health University Hospital

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

Official title: Decreasing Alzheimer's Disease and Related Dementias After Delirium- Exercise and Cognitive Training

Primary Specific Aim: Determine the effect of the combined physical exercise and cognitive training on the cognitive function of ICU survivors aged 50 and older. Hypothesis: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 weeks of combined physical exercise and cognitive training will have higher total index cognitive scores as assessed by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) at 3 and 6 months post randomization.

Secondary Specific Aim 1: Determine the effect of the combined physical exercise and cognitive training on physical performance, anxiety and depressive symptoms, and quality of life of ICU survivors aged 50 and older. Hypotheses: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 weeks of combined physical exercise and cognitive training will have higher physical performance as measured by short physical performance battery (SPPB) and two-minute step test, lower mood and anxiety symptoms as measured by Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) scale, and higher quality of life as measured by the Medical Outcomes Study 36-item short form (SF-36) at 3 and 6-months post randomization.

Exploratory Aim 2: To examine the mechanisms of action of combined training. Hypothesis: At the completion of treatment, the combined intervention group will show reduced serum levels of CRP, IL-1, IL-6, IL-8, TNF-α, S-100β, and GFAP and increased levels of BDNF, VEGF, and IGF-1 compared to the attention control, or either intervention alone groups.

Read the detailed description

Critical illness has deleterious consequences on both acute and chronic cognitive functions. Acute cognitive dysfunction manifests itself as delirium in the critically ill especially the elderly. Delirium is a complex neuropsychiatric syndrome characterized by acute and fluctuating changes in cognition and consciousness. 60% to 80% of critically ill ventilated older patients and 30% to 50% of those with less illness severity have delirium for at least one day of their ICU or hospital stay. Chronic cognitive dysfunction manifests as ICU acquired cognitive impairment and dementia after critical illness, affects multiple cognitive domains and persists years after hospital discharge. Up to 71% of critical illness survivors have cognitive impairment at one year after hospital discharge and close to 18% are diagnosed with new dementia including Alzheimer's disease within three years post ICU hospitalization.

Two million older Americans suffer from an episode of delirium during their intensive care unit (ICU) stay. Presence of delirium predisposes the elderly to immediate in-hospital complications including a longer length of ICU and hospital stay, increased risk of in-patient mortality and elevated costs of care. In addition, ICU delirium is associated with long-term post-discharge complications such as development of cognitive impairment and dementia. Current advances in the management of critical illness have notably improved the survival rates among this vulnerable segment of older adults. However, increased survival comes at a cost with as many as 70% of older ICU survivors who had an episode of delirium suffering from subsequent cognitive impairment and dementia. At present, there are no effective and scalable recovery models to remediate ICU acquired cognitive impairment and its attendant elevated dementia or Alzheimer's disease risk.

The inability to develop efficacious interventions to reduce ICU acquired cognitive impairment may stem from a limited understanding of the link between acute brain dysfunction (delirium) and chronic brain dysfunction (ICU acquired cognitive impairment, dementia or Alzheimer's disease). The investigators propose a recovery intervention guided by the pathophysiologic mechanisms implicated in producing critical illness delirium and elevated risk of cognitive impairment. The intervention targets inflammation, glial dysfunction and astrocyte activation along with restoration of neurotrophic factors while training function directly across multiple cognitive domains to reduce the burden of cognitive impairment among ICU survivors of delirium.

Over the past five years, Indiana University Center for Aging Research has developed a research infrastructure focused on delirium and delirium associated cognitive impairment, encompassing the ICU and post-ICU periods. This includes developing a bio-repository of serum delirium biomarkers, ICU based delirium trials, and post-ICU exercise and cognitive therapy recovery models. Building upon prior work and based on the pathophysiologic mechanisms mentioned above, the investigators now propose a novel home-based combined physical exercise and cognitive training program for older ICU survivors to improve cognitive impairment.

The study team is proposing a 2x2 factorial design randomized controlled trial (RCT) called "Decreasing Alzheimer's Disease and Related Dementias after Delirium-Exercise and Cognitive Training (DDD-ECT)" to evaluate the efficacy of 12 weeks of combined physical exercise and cognitive training on the primary outcome of cognitive function among older ICU survivors who experienced delirium or subsyndromal delirium during their ICU stay. The investigators propose to deliver these interventions via a facilitator-led, small group format using internet-enabled, multiparty-videoconference delivered directly into the participants' homes to achieve the study aims listed in the summary.

Being tested
Physical Exercise Intervention, Cognitive Training Intervention, Stretching Control, Cognitive Control
Keywords
Delirium, Alzheimer's Disease, Aging, Exercise Therapy, Cognitive Training
Medical subject headings
Delirium, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical Exercise InterventionBehavioural

    In home exercise intervention.

  • Cognitive Training InterventionBehavioural

    Also called Brain HQ

    Online cognitive training modules.

  • Stretching ControlBehavioural

    In home stretching.

  • Cognitive ControlBehavioural

    Also called Brain HQ

    Online control puzzles and games.

Study groups in NCT03095417
Study groupRoleWhat they receive
Physical Exercise and Cognitive TrainingExperimentalPhysical Exercise Intervention: The physical exercise portion of the combined intervention consists of 45 minutes of multi-modal physical exercise focused on seated aerobic and progressive resistance training designed to improve aerobic capacity, muscular strength and endurance consistent with current exercise recommendations. The study team will deliver 3 sessions per week for 3 months. Cognitive Intervention: The cognitive portion of the combined intervention consists of a suite of 24 programs called Brain HQ developed by Posit Science Inc., organized into six categories: attention, speed, memory, people skills, intelligence, and navigation. The DDD-ECT trial will use 45-minute sessions of Brain HQ exercises. The modules are designed to improve time-order judgment, visual discrimination, spatial-match, forward-span, instruction-following, and memory.
Receives: Behavioral: Physical Exercise Intervention; Behavioral: Cognitive Training Intervention
Physical Exercise and Cognitive ControlActive comparatorPhysical Exercise Intervention: The physical exercise portion of the combined intervention consists of 45 minutes of multi-modal physical exercise focused on seated aerobic and progressive resistance training designed to improve aerobic capacity, muscular strength and endurance consistent with current exercise recommendations. The study team will deliver 3 sessions per week for 3 months. Cognitive Control: This consists of up to 20 minutes of puzzles and games, 2 days per week for 3 months. The participants will use on-line Brain HQ Control Games hosted by Posit Science, Inc. as an attention control.
Receives: Behavioral: Physical Exercise Intervention; Behavioral: Cognitive Control
Cognitive Training and Stretching ControlActive comparatorStretching Control: This consists of up to 10 minutes of gentle stretching. The study team will deliver 3 sessions per week for 3 months. Cognitive Intervention: The cognitive portion of the combined intervention consists of a suite of 24 programs called Brain HQ developed by Posit Science Inc., organized into six categories: attention, speed, memory, people skills, intelligence, and navigation. The DDD-ECT trial will use 45-minute sessions of Brain HQ exercises. The modules are designed to improve time-order judgment, visual discrimination, spatial-match, forward-span, instruction-following, and memory. ly directing one session per week and available as needed for rest of the sessions.
Receives: Behavioral: Cognitive Training Intervention; Behavioral: Stretching Control
Cognitive Control and Stretching ControlSham comparatorStretching Control: This consists of up to 10 minutes of stretching. The study team will deliver 3 sessions per week for 3 months. Cognitive Control: This consists of up to 20 minutes of puzzles and games, 2 days per week for 3 months. The participants will use on-line Brain HQ Control Games hosted by Posit Science, Inc. as an attention control.
Receives: Behavioral: Stretching Control; Behavioral: Cognitive Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive Status Outcome at 6 Months

    The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) will measure cognitive status.

    The z-scores for the subscales have a mean of 0 and standard deviation of 1. The overall z-score is the mean of the 7-item z-scores. Z-scores above the standard deviation represent better cognitive outcomes.

    Measured: 6 months post study randomization

  2. Cognitive Status Outcome at 3 Months

    The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) will measure cognitive status.

    The z-scores for the subscales have a mean of 0 and standard deviation of 1. The overall z-score is the mean of the 7-item z-scores. Z-scores above the standard deviation represent better cognitive outcomes.

    Measured: 3 months post study randomization

Secondary outcomes (10)
  1. Physical Performance Scores at 3 Months

    The Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength.

    Ranges from 0-12: higher score is better outcome

    Measured: 3 month post study randomization

  2. Physical Performance Scores at 6 Months

    The Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength.

    Ranges from 0-12: higher score is better outcome

    Measured: 6 month post study randomization

  3. Cardiovascular Fitness Scores at 3 Months

    The 2-Minute Step Test will measure physical training effects on cardiovascular fitness.

    Number of steps, higher = better outcome

    Measured: 3 month post study randomization

  4. Cardiovascular Fitness Scores at 6 Months

    The 2-Minute Step Test will measure physical training effects on cardiovascular fitness.

    Number of steps, higher = better outcome

    Measured: 6 month post study randomization

  5. Depression Scores at 3 Months

    The Patient Health Questionnaire-9 (PHQ-9) will measure intervention effects on depression levels.

    Ranges from 0-27, higher score is worse outcome

    Measured: 3 month post study randomization

  6. Depression Scores at 6 Months

    The Patient Health Questionnaire-9 (PHQ-9) will measure intervention effects on depression levels.

    Ranges from 0-27, higher score is worse outcome

    Measured: 6 month post study randomization

  7. Anxiety Scores at 3 Months

    The Generalized Anxiety Disorder Scale (GAD-7) will measure intervention effects on anxiety levels.

    Ranges from 0-21, higher score is worse outcome

    Measured: 3 month post study randomization

  8. Anxiety Scores at 6 Months

    The Generalized Anxiety Disorder Scale (GAD-7) will measure intervention effects on anxiety levels.

    Ranges from 0-21, higher score is worse outcome

    Measured: 6 month post study randomization

  9. Quality of Life Scores at 3 Months

    The Medical Outcomes Study 36 item short form (SF-36) will measure participant quality of life scores.

    range of 0 - 100 (higher = better outcome)

    Measured: 3 month post study randomization

  10. Quality of Life Scores at 6 Months

    The Medical Outcomes Study 36 item short form (SF-36) will measure participant quality of life scores.

    range of 0 - 100 (higher = better outcome)

    Measured: 6 month post study randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2017
  2. Study start25 Sep 2017
  3. Primary completion15 Dec 2022
  4. Study completion15 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
249 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03095417
Sponsor's protocol ID
1608126693
Other IDs
R01AG055391
Acronym
IMPROVE
Status last verified
Feb 2024
First submitted
23 Mar 2017
Last updated
27 Mar 2024
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Khan SH, Perkins AJ, Unverzagt FW, Wang S, Moser LR, Moiz S, Jawaid S, Corlett D, Clark DO, Boustani MA, Gao S, Khan BA. Improving Recovery and Outcomes Every Day After the ICU (IMPROVE): A Randomized Controlled Trial. Crit Care Med. 2025 Aug 1;53(8):e1542-e1553. doi: 10.1097/CCM.0000000000006698. Epub 2025 May 22.

    PubMed 40402024
  • Wang S, Hammes J, Khan S, Gao S, Harrawood A, Martinez S, Moser L, Perkins A, Unverzagt FW, Clark DO, Boustani M, Khan B. Improving Recovery and Outcomes Every Day after the ICU (IMPROVE): study protocol for a randomized controlled trial. Trials. 2018 Mar 27;19(1):196. doi: 10.1186/s13063-018-2569-8.

    PubMed 29580264

Questions about this trial

What is this clinical trial studying?

A study testing Physical Exercise Intervention and Cognitive Training Intervention in people with Delirium and Alzheimer Disease, run by Indiana University at 6 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 27 Mar 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive Status Outcome at 6 Months (time frame: 6 months post study randomization). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03095417, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in